INSMED INC Operating Cash Flow
INSMED INC (INSM) reported Operating Cash Flow of -$311.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- INSMED INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$88.83M.
- INSMED INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$222.74M.
- INSMED INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$247.60M.
- INSMED INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$219.76M.
- INSMED INC net cash provided by (used in) operating activities for fiscal 2025 was -$935.01M.
- INSMED INC net cash provided by (used in) operating activities for fiscal 2024 was -$683.88M.
- INSMED INC net cash provided by (used in) operating activities for fiscal 2023 was -$536.25M.
- INSMED INC net cash provided by (used in) operating activities for fiscal 2022 was -$400.44M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$88.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$311.57M 10-Q · filed 2026-08-06 | -$559.16M derived: sum of 3 quarters · filed 2026-08-06 | -$778.92M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$222.74M 10-Q · filed 2026-05-07 | -$470.33M derived: sum of 2 quarters · filed 2026-05-07 | -$690.10M derived: sum of 3 quarters · filed 2026-05-07 | -$895.66M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$247.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$467.36M derived: sum of 2 quarters · filed 2026-02-19 | -$672.93M derived: sum of 3 quarters · filed 2026-08-06 | -$935.01M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | -$219.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$425.33M derived: sum of 2 quarters · filed 2026-08-06 | -$687.42M 10-Q · filed 2025-10-30 | -$883.40M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$205.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$467.66M 10-Q · filed 2026-08-06 | -$663.64M derived: sum of 3 quarters · filed 2026-08-06 | -$844.55M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$262.09M 10-Q · filed 2026-05-07 | -$458.07M derived: sum of 2 quarters · filed 2026-05-07 | -$638.98M derived: sum of 3 quarters · filed 2026-05-07 | -$761.93M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$195.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$376.89M derived: sum of 2 quarters · filed 2026-02-19 | -$499.85M derived: sum of 3 quarters · filed 2026-02-19 | -$683.88M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | -$180.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$303.87M derived: sum of 2 quarters · filed 2025-10-30 | -$487.90M 10-Q · filed 2025-10-30 | -$618.72M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | -$122.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$306.99M 10-Q · filed 2025-08-07 | -$437.81M derived: sum of 3 quarters · filed 2026-02-19 | -$574.14M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | -$184.03M 10-Q · filed 2025-05-08 | -$314.85M derived: sum of 2 quarters · filed 2026-02-19 | -$451.19M derived: sum of 3 quarters · filed 2026-02-19 | -$573.98M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | -$130.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$267.15M derived: sum of 2 quarters · filed 2026-02-19 | -$389.94M derived: sum of 3 quarters · filed 2026-02-19 | -$536.25M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | -$136.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$259.13M derived: sum of 2 quarters · filed 2024-10-31 | -$405.43M 10-Q · filed 2024-10-31 | -$508.58M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | -$122.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$269.10M 10-Q · filed 2024-08-08 | -$372.24M derived: sum of 3 quarters · filed 2025-02-20 | -$462.07M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | -$146.30M 10-Q · filed 2024-05-09 | -$249.45M derived: sum of 2 quarters · filed 2025-02-20 | -$339.28M derived: sum of 3 quarters · filed 2025-02-20 | -$441.58M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | -$103.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$192.98M derived: sum of 2 quarters · filed 2025-02-20 | -$295.28M derived: sum of 3 quarters · filed 2025-02-20 | -$400.44M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | -$89.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$192.13M derived: sum of 2 quarters · filed 2023-10-26 | -$297.29M 10-Q · filed 2023-10-26 | -$381.42M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-06-30 | -$102.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$207.46M 10-Q · filed 2023-08-03 | -$291.59M derived: sum of 3 quarters · filed 2024-02-22 | -$367.04M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-03-31 | -$105.16M 10-Q · filed 2023-05-04 | -$189.29M derived: sum of 2 quarters · filed 2024-02-22 | -$264.74M derived: sum of 3 quarters · filed 2024-02-22 | -$340.18M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | -$84.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$159.58M derived: sum of 2 quarters · filed 2024-02-22 | -$235.02M derived: sum of 3 quarters · filed 2024-02-22 | -$363.30M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | -$75.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$150.89M derived: sum of 2 quarters · filed 2022-10-27 | -$279.17M 10-Q · filed 2022-10-27 | -$345.96M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | -$75.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$203.72M 10-Q · filed 2022-08-04 | -$270.52M derived: sum of 3 quarters · filed 2023-02-23 | -$329.19M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | -$128.28M 10-Q · filed 2022-05-05 | -$195.07M derived: sum of 2 quarters · filed 2023-02-23 | -$253.74M derived: sum of 3 quarters · filed 2023-02-23 | -$289.69M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | -$66.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$125.46M derived: sum of 2 quarters · filed 2023-02-23 | -$161.41M derived: sum of 3 quarters · filed 2023-02-23 | -$219.35M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | -$58.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$94.62M derived: sum of 2 quarters · filed 2021-10-28 | -$152.56M 10-Q · filed 2021-10-28 | -$196.96M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2020-06-30 | -$35.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$93.89M 10-Q · filed 2021-08-05 | -$138.29M derived: sum of 3 quarters · filed 2022-02-17 | -$190.66M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2020-03-31 | -$57.94M 10-Q · filed 2021-05-06 | -$102.34M derived: sum of 2 quarters · filed 2022-02-17 | -$154.71M derived: sum of 3 quarters · filed 2022-02-17 | -$234.74M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2019-12-31 | -$44.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$96.77M derived: sum of 2 quarters · filed 2022-02-17 | -$176.80M derived: sum of 3 quarters · filed 2022-02-17 | -$250.65M 10-K · filed 2022-02-17 | |||
| 2019-09-30 | -$52.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$132.40M derived: sum of 2 quarters · filed 2020-10-29 | -$206.25M 10-Q · filed 2020-10-29 | -$276.41M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | -$80.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$153.88M 10-Q · filed 2020-08-06 | -$224.04M derived: sum of 3 quarters · filed 2021-02-25 | -$289.53M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$73.85M 10-Q · filed 2020-04-30 | -$144.01M derived: sum of 2 quarters · filed 2021-02-25 | -$209.50M derived: sum of 3 quarters · filed 2021-02-25 | -$264.41M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$70.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$135.65M derived: sum of 2 quarters · filed 2021-02-25 | -$190.56M derived: sum of 3 quarters · filed 2021-02-25 | -$257.98M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$65.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$120.40M derived: sum of 2 quarters · filed 2019-10-30 | -$187.81M 10-Q · filed 2019-10-30 | -$188.44M 10-Q · filed 2018-10-30 | -$236.03M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | -$54.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$122.33M 10-Q · filed 2019-08-01 | -$122.95M 10-Q · filed 2018-08-02 | -$170.55M derived: sum of 3 quarters · filed 2020-02-25 | -$208.78M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | -$67.41M 10-Q · filed 2019-05-07 | -$68.04M 10-Q · filed 2018-05-02 | -$115.63M derived: sum of 2 quarters · filed 2020-02-25 | -$153.87M derived: sum of 3 quarters · filed 2020-02-25 | -$190.12M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$48.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$86.46M derived: sum of 2 quarters · filed 2020-02-25 | -$122.70M derived: sum of 3 quarters · filed 2020-02-25 | -$159.62M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | -$38.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$74.48M derived: sum of 2 quarters · filed 2018-10-30 | -$111.40M 10-Q · filed 2018-10-30 | -$169.36M derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-06-30 | -$36.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$73.16M 10-Q · filed 2018-08-02 | -$131.12M derived: sum of 3 quarters · filed 2019-02-22 | -$162.10M derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-03-31 | -$36.91M 10-Q · filed 2018-05-02 | -$94.87M derived: sum of 2 quarters · filed 2019-02-22 | -$125.86M derived: sum of 3 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | -$57.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$88.94M derived: sum of 2 quarters · filed 2019-02-22 | -$146.71M 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | -$30.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$88.75M 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | -$57.77M 10-Q · filed 2017-08-03 | ||||||
| 2015-12-31 | -$100.70M 10-K · filed 2018-02-23 | ||||||
| 2012-12-31 | -$8.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$18.11M derived: sum of 2 quarters · filed 2013-03-18 | -$25.40M derived: sum of 3 quarters · filed 2013-03-18 | -$31.01M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | -$9.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$16.47M derived: sum of 2 quarters · filed 2012-11-07 | -$22.09M 10-Q · filed 2012-11-07 | -$28.15M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2012-06-30 | -$7.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$12.90M 10-Q · filed 2012-08-07 | -$18.96M derived: sum of 3 quarters · filed 2013-03-18 | -$26.97M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2012-03-31 | -$5.61M 10-Q · filed 2012-05-08 | -$11.68M derived: sum of 2 quarters · filed 2013-03-18 | -$19.68M derived: sum of 3 quarters · filed 2013-03-18 | -$30.71M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-12-31 | -$6.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$14.07M derived: sum of 2 quarters · filed 2013-03-18 | -$25.10M derived: sum of 3 quarters · filed 2013-03-18 | -$30.20M 10-K · filed 2013-03-18 | |||
| 2011-09-30 | -$8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$19.03M derived: sum of 2 quarters · filed 2012-11-07 | -$24.14M 10-Q · filed 2012-11-07 | -$33.06M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | -$11.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$16.13M 10-Q · filed 2012-08-07 | -$25.05M derived: sum of 3 quarters · filed 2013-03-18 | -$26.09M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | -$5.11M 10-Q · filed 2012-05-08 | -$14.03M derived: sum of 2 quarters · filed 2013-03-18 | -$15.07M derived: sum of 3 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | -$8.92M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$9.96M derived: sum of 2 quarters · filed 2013-03-18 | -$7.72M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $1.20M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $2.23M 10-Q/A · filed 2011-08-08 | ||||||
| 2009-12-31 | -$11.01M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |